ALTA-2618

N/A

Report date: 2024/08/23 20:00:42
NME

Base Information

Drug NameALTA-2618
Drug Alias NameALTA-2618
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase AKT1 inhibitors
TargetsSerine/threonine-protein kinase AKT1
Therapy Area/IndicationsSolid tumoursNeoplasm MetastasisEndometrial Neoplasms +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTaiwanAustralia +[8
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAlterome Therapeutics Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumoursNeoplasm MetastasisEndometrial Neoplasms +[4
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A